Last Close
2.36 $
Jul 7, 26
Market Cap
197.7 M $
Q1 2026 (TTM)
52-Week Range
%+60.5
%64.5
0.45
0.44
%-25.1
-%39.7
1M
+18.6%
3M
+7.8%
6M
+33.3%
YTD
+31.1%
1Y
+60.5%
3Y
+31.1%
Returns are computed from split-adjusted closes; dividends are not included.
Stock and gold/silver returns are in USD (metals converted into the stock's currency). The S&P 500 index is measured in its own currency.
PLX last closed at 2.36 $ (Jul 7, 26). Price data is refreshed after every trading day.
Protalix Biotherapeutics Inc trades at a trailing-twelve-month P/E of 12.89. See the comparison tables on the Peers tab for the industry context.
Protalix Biotherapeutics Inc (PLX) has a market capitalization of approximately 197.7 M $ as of the latest reported period.
Key peers of Protalix Biotherapeutics Inc include RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S., Mesoblast Ltd, TELIX Pharmaceuticals Ltd. A detailed metric comparison is available on the Peers tab.
Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.